Literature DB >> 11860527

Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors.

B Weber1, E Schlicker.   

Abstract

The modulation of dopamine release from the guinea-pig retina was studied using maximally effective concentrations of 10 agonists acting on G(i)-, G(s)- or G(q)-protein-coupled receptors (PCRs). Retinal discs were preincubated with [(3)H]noradrenaline and superfused; tritium overflow was evoked electrically. The following compounds acting on G(i)-PCRs reduced the tritium overflow, which represents quasi-physiological dopamine release under the experimental conditions of our study: the dopamine and alpha(2)-adrenoceptor agonist B-HT 920 by 95%, the muscarinic agonist oxotremorine by 96%, melatonin by 94%, the cannabinoid agonist WIN 55,212-2 by 71% and histamine by 66%. Tritium overflow was not affected by serotonin or by agonists acting on G(s)-PCRs (ACTH1-24 and the beta-adrenoceptor agonist procaterol) and G(q)-PCRs (angiotensin II and bradykinin). The effects of B-HT 920, oxotremorine and melatonin were studied in more detail using appropriate antagonists. The inhibitory effect of a submaximally active concentration of B-HT 920 was counteracted by the dopamine D(2/3) antagonist haloperidol but not affected by the alpha(2)-adrenoceptor antagonist phentolamine. The muscarinic antagonist atropine shifted to the right the concentration-response curve of oxotremorine (pA(2) 8.7) and the melatonin MT(2) antagonist 4-P-PDOT produced a rightward shift of the concentration-response curve of melatonin (pA(2) 10.6). Melatonin was also studied in superfused brain slices (from the guinea-pig) preincubated with [(3)H]noradrenaline. The electrically evoked tritium overflow in cerebrocortical, hippocampal and hypothalamic slices (representing quasi-physiological noradrenaline release) and in striatal slices (representing quasi-physiological dopamine release) was not affected by melatonin at a concentration that causes the maximum effect in retinal discs. In conclusion, dopamine release in the guinea-pig retina is inhibited via G(i)-PCRs including dopamine (D(2/3)), muscarinic and melatonin (MT(2)) receptors but not affected via any of the G(s)- or G(q)-PCRs under study. Unlike in the retina, melatonin fails to inhibit monoamine release in four brain regions of the guinea-pig.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11860527     DOI: 10.1046/j.1472-8206.2001.00056.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  12 in total

Review 1.  Retinopetal axons in mammals: emphasis on histamine and serotonin.

Authors:  Matthew J Gastinger; Ning Tian; Tamas Horvath; David W Marshak
Journal:  Curr Eye Res       Date:  2006 Jul-Aug       Impact factor: 2.424

2.  Effects of histamine on light responses of amacrine cells in tiger salamander retina.

Authors:  Yongchun Yu; Hiromasa Satoh; Alejandro Vila; Samuel M Wu; David W Marshak
Journal:  Neurochem Res       Date:  2010-09-28       Impact factor: 3.996

3.  Muscarinic acetylcholine receptor localization and activation effects on ganglion response properties.

Authors:  Christianne E Strang; Jordan M Renna; Franklin R Amthor; Kent T Keyser
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

4.  Topical mydriatics affect light-evoked retinal responses in anesthetized mice.

Authors:  Deb Kumar Mojumder; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

5.  Histamine receptors in mammalian retinas.

Authors:  Matthew J Gastinger; Alistair J Barber; Noga Vardi; David W Marshak
Journal:  J Comp Neurol       Date:  2006-04-20       Impact factor: 3.215

6.  Histamine elevates free intracellular calcium in mouse retinal dopaminergic cells via H1-receptors.

Authors:  Renata Frazão; Douglas G McMahon; Walter Schunack; Proleta Datta; Ruth Heidelberger; David W Marshak
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

7.  Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.

Authors:  J Günther; K Schulte; D Wenzel; B Malinowska; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

Review 8.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

Review 9.  Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.

Authors:  Despina Kokona; Panagiota-Christina Georgiou; Mihalis Kounenidakis; Foteini Kiagiadaki; Kyriaki Thermos
Journal:  Neural Plast       Date:  2016-01-06       Impact factor: 3.599

Review 10.  Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain.

Authors:  Jean-François Bouchard; Christian Casanova; Bruno Cécyre; William John Redmond
Journal:  Neural Plast       Date:  2015-12-29       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.